[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":19275000000.0,"RepaymentsOfOtherShortTermDebt_2_Q2_USD":0.0,"CommonStockDividendsPerShareDeclared_0_Q2_USD":1.18,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q2_USD":-29000000.0,"ForeignCurrencyTransactionGainLossBeforeTax_2_Q2_USD":-34000000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q2_shares":0.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2_Q2_shares":4000000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":-614000000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":-1042000000.0,"AllocatedShareBasedCompensationExpenseNetOfTax_1_Q2_USD":198000000.0,"ProceedsFromPaymentsForOtherFinancingActivities_2_Q2_USD":20000000.0,"AllocatedShareBasedCompensationExpenseNetOfTax_2_Q2_USD":378000000.0,"DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_0_Q2_USD":156000000.0,"DerivativeFairValueOfDerivativeAsset_0_Q2_USD":223000000.0,"DerivativeFairValueOfDerivativeLiability_0_Q2_USD":77000000.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_1_Q2_USD":38000000.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_2_Q2_USD":77000000.0,"EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_0_Q2_USD":91000000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_2_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_2_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_2_Q2_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-33907000000.0,"LongTermInvestments_0_Q2_USD":225000000.0,"TreasuryStockValueAcquiredCostMethod_2_Q2_USD":662000000.0,"TreasuryStockValueAcquiredCostMethod_1_Q2_USD":19000000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":77000000.0,"DividendsCommonStockCash_2_Q2_USD":3859000000.0,"DividendsCommonStockCash_1_Q2_USD":2105000000.0,"EarningsPerShareDiluted_1_Q2_USD":-0.46,"EarningsPerShareDiluted_2_Q2_USD":1.43,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":1968000000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q2_USD":-756000000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_2_Q2_USD":2244000000.0,"TreasuryStockShares_0_Q2_shares":24140541.0,"TreasuryStockValue_0_Q2_USD":1958000000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":-477000000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":2432000000.0,"ShortTermBorrowings_0_Q2_USD":64000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":6017000000.0,"PaymentsOfDividends_2_Q2_USD":3515000000.0,"ShortTermInvestments_0_Q2_USD":23000000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":76463000000.0,"PaymentsForProceedsFromOtherInvestingActivities_2_Q2_USD":-1454000000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":236000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":455000000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":23306000000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_2_Q2_USD":0.0,"ProceedsFromIssuanceOfLongTermDebt_2_Q2_USD":3000000000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_2_Q2_USD":-881000000.0,"GoodwillAcquiredDuringPeriod_2_Q2_USD":27044000000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1_Q2_USD":-43000000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_2_Q2_USD":-99000000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_1_Q2_USD":-12000000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_2_Q2_USD":-27000000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-434000000.0,"ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic_1_Q2_USD":18000000.0,"ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic_2_Q2_USD":28000000.0,"ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_1_Q2_USD":18000000.0,"ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_2_Q2_USD":28000000.0,"OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_2_Q2_USD":-4000000.0,"PaymentForContingentConsiderationLiabilityFinancingActivities_2_Q2_USD":129000000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_2_Q2_USD":38138000000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":32000000.0,"PaymentsToAcquireOtherInvestments_2_Q2_USD":192000000.0,"ProceedsFromRepaymentsOfCommercialPaper_2_Q2_USD":0.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_2_Q2_USD":1429000000.0,"RepaymentsOfLongTermDebtAndCapitalSecurities_2_Q2_USD":3763000000.0,"ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_2_Q2_USD":853000000.0,"ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_1_Q2_USD":853000000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q2_USD":1582000000.0,"PaymentOfFinancingAndStockIssuanceCosts_2_Q2_USD":20000000.0,"OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_1_Q2_USD":4000000.0,"OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_2_Q2_USD":-11000000.0,"OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_1_Q2_USD":-9000000.0,"GoodwillImpairedAccumulatedImpairmentLoss_0_Q2_USD":0.0,"GoodwillTranslationAndPurchaseAccountingAdjustments_2_Q2_USD":21000000.0,"ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_2_Q2_USD":0.0,"IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_2_Q2_USD":204000000.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q2_USD":1040000000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q2_USD":87010000000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":728000000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":1363000000.0,"LongTermDebtAndCapitalLeaseObligationsCurrent_0_Q2_USD":5307000000.0,"LossContingencyAccrualAtCarryingValue_0_Q2_USD":330000000.0,"MinorityInterestPeriodIncreaseDecrease_2_Q2_USD":24000000.0,"MinorityInterestPeriodIncreaseDecrease_1_Q2_USD":24000000.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_1_Q2_USD":441000000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_2_Q2_USD":214000000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":0.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":0.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_1_Q2_USD":0.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_2_Q2_USD":0.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_1_Q2_USD":-2000000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_2_Q2_USD":-4000000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_2_Q2_USD":121000000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_2_Q2_USD":2961000000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":2244000000.0,"InvestmentIncomeInterest_2_Q2_USD":153000000.0,"ProfitLoss_1_Q2_USD":-739000000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":4908000000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":3130000000.0,"Revenues_1_Q2_USD":10425000000.0,"Revenues_2_Q2_USD":19044000000.0,"StockholdersEquity_0_Q2_USD":14708000000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"CommonStockSharesAuthorized_0_Q2_shares":4000000000.0,"ProfitLoss_2_Q2_USD":2271000000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_Q2_pure":0.21,"InterestExpense_1_Q2_USD":632000000.0,"InterestExpense_2_Q2_USD":1195000000.0,"OperatingIncomeLoss_1_Q2_USD":752000000.0,"OperatingIncomeLoss_2_Q2_USD":4355000000.0,"PaymentsForRepurchaseOfCommonStock_2_Q2_USD":662000000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":3527000000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":5222000000.0,"ShareBasedCompensation_2_Q2_USD":455000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":1647000000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":10547000000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":302000000.0,"NetIncomeLoss_1_Q2_USD":-738000000.0,"NetIncomeLoss_2_Q2_USD":2272000000.0,"AccountsReceivableNetCurrent_0_Q2_USD":8354000000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-3435000000.0,"Assets_0_Q2_USD":149530000000.0,"AssetsCurrent_0_Q2_USD":21256000000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":6017000000.0,"CommonStockSharesIssued_0_Q2_shares":1788423670.0,"CostsAndExpenses_1_Q2_USD":9673000000.0,"CostsAndExpenses_2_Q2_USD":14689000000.0,"Depreciation_1_Q2_USD":149000000.0,"Depreciation_2_Q2_USD":264000000.0,"EffectOfExchangeRateOnCashAndCashEquivalents_2_Q2_USD":-38000000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":46000000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":134000000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":543000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-240000000.0,"InventoryNet_0_Q2_USD":4059000000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":149530000000.0,"LiabilitiesCurrent_0_Q2_USD":24646000000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-4992000000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-35781000000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":6904000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":1568000000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-756000000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":5419000000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":1850000000.0,"OtherAssetsNoncurrent_0_Q2_USD":4009000000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":314000000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_2_Q2_USD":559000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":1647000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":1564000000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":16953000000.0,"StockIssuedDuringPeriodValueAcquisitions_1_Q2_USD":24409000000.0,"StockIssuedDuringPeriodValueAcquisitions_2_Q2_USD":24409000000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-476000000.0,"NetIncomeLossAttributableToNoncontrollingInterest_2_Q2_USD":-1000000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":2433000000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q2_USD":-1000000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2_Q2_USD":-1000000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":262000000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":161000000.0,"CommonStockValueOutstanding_0_Q2_USD":18000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":-693000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":2405000000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":-257000000.0,"InvestmentIncomeInterest_1_Q2_USD":18000000.0,"StockIssued1_2_Q2_USD":23979000000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q2_USD":-1000000.0,"MinorityInterest_0_Q2_USD":24000000.0,"ImpairmentOfIntangibleAssetsFinitelived_2_Q2_USD":0.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":4785000000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":-0.07,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.06,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":466000000.0,"IncreaseDecreaseInInventories_2_Q2_USD":304000000.0,"LongTermDebtAndCapitalLeaseObligations_0_Q2_USD":82061000000.0,"PrepaidExpenseAndOtherAssets_0_Q2_USD":2803000000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":10327000000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_2_Q2_USD":129000000.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":85970000000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":75423000000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-802000000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-874000000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":14732000000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_Q2_USD":881000000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":3711000000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":5653000000.0,"EarningsPerShareBasic_1_Q2_USD":-0.46,"EarningsPerShareBasic_2_Q2_USD":1.44,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q2_USD":8213000000.0,"Goodwill_0_Q2_USD":42669000000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":1400000000.0,"StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_0_Q2_USD":3500000000.0,"Ticker":"ABBV","CIK":"1551152","name":"ABBVIE INC.","OfficialName":"AbbVie Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"276158647867.0","Country":"United States","Sector":"Health Care","Industry":"Other Pharmaceuticals","Market":"NYSE","SP500":"SP500","filed":"20200804"}]